Aeglea BioTherapeutics Inc. (AGLE) surged 5.79% or 0.5 to $9.13. It is approximately 69387 shares traded, which is 27.62% compare to the average total volume 251237. The market cap of AGLE is $200.81 million. The year to date change is 66.2%. The 52 week price range is from $3.75 to $12.0. Price of AGLE have changed -1.60% during last week. It have changed -8.68% over last month, 4.67% over last 3 months, -7.60% over last 6 months and 90.93% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.29. It is 1.75% above current price. The 200-day Moving Averages for AGLE is 9.02. It is -1.20% below current price. The 52-week High is 12.0. It is 31.43% from the current price. The 52-week Low is 3.75. It is -58.93% from current price.
There are some statistics of AGLE. It is has market cap $200.81 million. The share outstanding is 22.00 million. The average volume is 251237. The revenue is 1.26M. The percent of top 15 Institution holding is 62.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -46.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -43.43%.